Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

NCT02535611 is registered in ClinicalTrials.gov with Mazandaran University of Medical Sciences as lead sponsor.

NCT NCT02535611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02535611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome
Lead sponsor
Mazandaran University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2015
Completion date
September 30, 2017
Enrollment
47 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

excitotoxicity, ischemic stroke, memantine